Agah Ramtin's most recent trade in RenovoRx Inc was a trade of 40,983 Common Stock done . Disclosure was reported to the exchange on Jan. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 47,460 | - | - | Common Stock | |
RenovoRx Inc | Agah Ramtin | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrants | |
RenovoRx Inc | Agah Ramtin | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 125,132 | 125,132 | - | - | Stock Option | |
RenovoRx Inc | Agah Ramtin | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 28,424 | 28,424 | - | - | Stock Option | |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 65,000 | 65,000 | - | - | Employee Stock Option (right to buy) | |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2022 | 975,000 | 1,295 | - | 0 | Common Stock | |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2022 | 975,000 | 975,000 | - | 0 | Common Stock | |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 07 Jun 2022 | 5,182 | 6,477 | - | 1.9 | 10,001 | Common Stock |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 21,398 | 21,398 | - | - | Employee Stock Option (right to buy) | |
RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 52,203 | 52,203 | - | - | Employee Stock Option (right to buy) |